Arlo (ARLO) CFO disposes of 125K shares; weighted avg $17.7124
Rhea-AI Filing Summary
Kurtis Joseph Binder, Chief Financial Officer of Arlo Technologies (ARLO), reported a sale of common stock. On 09/02/2025 he disposed of 125,000 shares at a weighted average price of $17.7124 per share, with transaction prices ranging from $17.12 to $17.99. The sales were made pursuant to a Rule 10b5-1 trading plan adopted May 15, 2025. After the reported sale, the filing shows 684,615 shares beneficially owned by the reporting person in a direct capacity. The Form 4 was signed by an attorney-in-fact on 09/03/2025 and was filed by one reporting person.
Positive
- Sale executed under a Rule 10b5-1 trading plan, indicating the transaction followed a pre-established schedule.
- Reporting person retains a substantial direct holding of 684,615 shares after the sale.
Negative
- Insider disposed of 125,000 shares, which reduced the reporting person's stake.
- Form does not state percentage ownership of outstanding shares, so relative ownership and control impact cannot be determined from this filing.
Insights
TL;DR: Insider sale under an established 10b5-1 plan reduces holdings but follows an approved trading schedule.
The disclosure indicates a pre-planned, Rule 10b5-1-compliant sale of 125,000 shares by the CFO, which signals adherence to insider trading policies and reduces the risk of allegations of opportunistic trading. The plan adoption date (May 15, 2025) precedes the transaction date, supporting the affirmative defense. The remaining direct holding of 684,615 shares suggests the reporting person retains a material stake, but the filing does not state percentage ownership relative to outstanding shares, so materiality to control cannot be assessed from this form alone.
TL;DR: Routine insider liquidity event; sale price range and weighted average are disclosed.
The Form 4 provides transaction specifics: 125,000 shares sold at a weighted average of $17.7124 and a price range of $17.12 to $17.99. These details allow precise calculation of gross proceeds but the filing does not disclose proceeds total explicitly. Because the sale was made under a documented 10b5-1 plan, it is treated as planned liquidity rather than an ad hoc market signal. The report is factual and does not include derivative transactions or amendments.